MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic (Nasdaq: HOLX) announced today that it has completed regulatory filings needed to make Panther Trax ® available in a number of countries and regions.

Hologic, Inc. HOLX recently announced the receipt of Health Canada approval for the new Panther Fusion system and Panther Fusion assays for respiratory virus infections. The Panther Fusion respiratory ...

Hologic, Inc. HOLX recently progressed in terms of the international launch of Panther Trax, representing the newest addition to the Panther Scalable Solutions (PSS) portfolio of products. The company ...

Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it is now offering its Panther Fusion ® SARS-CoV-2/Flu A/B/RSV assay and its Novodiag ® RESP-4 molecular ...

New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care A variety of complex factors, ...

In the fourth quarter of fiscal 2025, Diagnostics revenues increased 1.5% in constant currency (CC), driven by higher core ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, ...

Hologic offered an early peek into its upcoming quarterly earnings report, during the kickoff of the J.P. Morgan Healthcare Conference. With sums described as estimates ahead of the company’s full ...

The stock price of Hologic (NASDAQ: HOLX), a medical devices company focused on women’s health, has seen a 7% rise over the last twenty-one trading days, while it is up just 12% over the last year.